It has been shown that EZH2 is enriched at the D4Z4 region in healthy control primary myocytes, but not in FSHD patient-derived cells, contributing to epigenetic de-repression of DUX4 in FSHD41. The gene discussed is EZH2; the disease is facioscapulohumeral muscular dystrophy.